PRODUCT INFORMATION
BIMADINE PDR Sulfadimidine 25g
BENEFITS •
•
•
Broad
spectrum
treatment
and
control
of
diseases
in
calves Powerful
action
of
sulfadimadine,
effective
against
a
wide
range
of
pathogens
Readily
soluble
in
water
for
ease
of
administration
PACKAGING LIST NO.
UNIT PACKAGE
CASE SIZE
1BIM003
25g
100
See
reverse
side
for
full
indications,
administration and
dosage.
Bimeda®
a
division
of
Cross
Vetpharm
Group
Ltd. Broomhill
Road
I
Tallaght
I
Dublin
24
I
Ireland
Tel:
+353
1
4667900
Fax:
+353
1
4515803
Web:
www.bimedaexports.com
TECHNICAL PRODUCT INFORMATION INFORMATION
BIMADINE POWDER Presentation White
polythene/aluminium
sachets
containing
a
white
or
almost
white
powder
which
is
intended,following
suspension
in
drinking
water,
for
oral
administration
to
animals.
Each
sachet
contains
Sulfadimadine
99.01%w/w.
Uses For
the
treatment
and
control
of
diseases
in
monogastric
calves
caused
by
or
associated
with
organisms
sensitive
to
sulfadimadine. Dosage and Administration For
oral
administration.
Recommended
dosage
2g
per
10kg
bodyweight
(equivalent
to
1
sachet
per
125
kg
bodyweight),
followed
by
daily
doses
of
1g
per
10kg
bodyweight
(equivalent
to
1
sachet
per
250
kg
bodyweight)
for
a
further
2
days
only.
Withdrawal Periods Animals
must
not
be
slaughtered
for
human
consumption
during
treatment.
Animals
may
be
slaughtered
for
human
consumption
only
after
28
days
from
the
last
treatment.
Pharmaceutical Precautions Keep
out
of
reach
and
sight
of
children.
Do
not
store
above
25°C
Legal Category POM Package Quantities
100
x
25g
packs.
VPA
10126/27/1
Contra-indications, Warnings, etc. For
animal
treatment
only.
Not
to
be
used
in
animals
known
to
be
hypersensitive
to
the
active
ingredient.
The
procaine
of
procaine
penicillin
and
local
anaesthetics
of
the
procaine
group
are
antagonistic
and
should
not
be
used
during
treatment.
There
is
interaction
and
antagonism
between
sulfonamides
and
vitamin
B
complex. As
with
all
sulphonamides,
prolonged
treatment
may
give
rise
to
Vitamin
K
deficiency,
agranulocytosis
and
haemolytic
anaemia
and
should
therefore
be
avoided.
This
information
should
be
used
as
a
general
guide,
for
more
specific
instructions on the use of Bimeda® products always read the product label carefully.
Bimeda®
a
division
of
Cross
Vetpharm
Group
Ltd. Broomhill
Road
I
Tallaght
I
Dublin
24
I
Ireland
Tel:
+353
1
4667900
Fax:
+353
1
4515803
Web:
www.bimedaexports.com